SLC34A2 and colorectal carcinoma: On the other hand, the inhibition of cell growth YC-1/BHA could be reversed by p-EZH2. These data imply that each element in SLC34A2-ROS-HIF-1-EZH2 signaling pathway contributes to the proliferation of cisplatin resistance to apoptosis in CRC.